Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
28.66
+0.46 (+1.63%)
Official Closing Price
Updated: 7:00 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their Lead?
May 19, 2024
Billionaire money managers have bought millions of shares of both Pfizer and Walgreens Boots Alliance this year.
Via
The Motley Fool
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 18, 2024
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA).
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
May 17, 2024
Moderna wins a crucial legal battle at the European Patent Office against Pfizer and BioNTech over Covid-19 vaccine patents.
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale
May 17, 2024
GSK is fully exiting its position and will no longer hold any ordinary shares in Haleon, maker of Sensodyne toothpaste and Advil painkillers.
Via
Benzinga
Spotlight on Pfizer: Analyzing the Surge in Options Activity
May 16, 2024
Via
Benzinga
Is This a Setback for Moderna?
May 14, 2024
Moderna's shares slipped after the company announced the delay.
Via
The Motley Fool
7 Value Stocks to Buy and Hold for a Decade of Dominance
May 17, 2024
Discover the enduring value of seven key value stocks to buy and hold in diverse sectors, presenting unparalleled opportunities.
Via
InvestorPlace
Could Novavax Become the Next Moderna?
May 17, 2024
Sanofi believes in Novavax's vaccine strengths...
Via
The Motley Fool
Which Is The Best Investment For You? High Yield Pfizer Or Higher Growth Merck?
May 16, 2024
It depends on what your goals, objectives, and risk tolerances are.
Via
Talk Markets
2 Top Growth Stocks Down 24% and 50% to Buy With $100
May 16, 2024
Investors might be remiss to overlook these stocks.
Via
The Motley Fool
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
May 16, 2024
On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France,...
Via
Benzinga
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
May 16, 2024
AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade
May 16, 2024
The FTC is putting these three drug stocks at risk by trying to strip their therapies of protection from generics.
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
May 16, 2024
From
Arvinas Inc.
Via
GlobeNewswire
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report
May 16, 2024
In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc has agreed to pay up to $250 million.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
10 Health Care Stocks With Whale Alerts In Today's Session
May 15, 2024
Via
Benzinga
Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades'
May 15, 2024
Pfizer is looking to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer medicines platform.
Via
Benzinga
Exposures
COVID-19
7 Cheap Value Stocks to Buy Now: May 2024
May 15, 2024
Worried about a potential market correction? These seven cheap value stocks are bargains today regardless of the broader economic climate.
Via
InvestorPlace
3 No-Brainer Stocks to Buy With $500 Right Now
May 15, 2024
A modest amount of money can go a long way on Wall Street when it's put to work in game-changing companies.
Via
The Motley Fool
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
May 14, 2024
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
May 14, 2024
These healthcare stocks offer completely different approaches to long-term investment gains.
Via
The Motley Fool
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
May 13, 2024
Pfizer seeks to expands its reach with 'Pfizer for All,' offering direct-to-consumer medical services, including COVID treatments & telehealth.
Via
Benzinga
Exposures
COVID-19
Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector
May 13, 2024
Pfizer and AstraZeneca invest over $1 billion in France's healthcare sector, bolstering R&D capabilities and job creation.
Via
Benzinga
How Viking Therapeutics Stock Could 30x
May 13, 2024
This mid-cap biopharma may one day be a titan of the industry.
Via
The Motley Fool
3 Stocks That Suddenly Drew in Options Traders
May 13, 2024
Three discounted stocks caught the attention of call option buyers last week, and they have Wall Street analysts to back them through double-digit upside.
Via
MarketBeat
Generis Welcomes Max Kelleher as New Chief Executive Officer
May 14, 2024
LONDON - May 14, 2024 - PRLog -- Generis, creator of the cloud data, content, and business process management platform CARA™, today announced that Max Kelleher will be stepping into the role of Chief...
Via
PRLog
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock
May 13, 2024
Pfizer stock currently has a 5.9% dividend yield, making it an attractive target for income investors.
Via
The Motley Fool
'Seems Low:' Elon Musk Questions Pfizer's $0 Tax Bill, But Did Tesla Pony Up To Uncle Sam?
May 13, 2024
In December 2021, Musk paid a record-breaking $11 billion in federal income taxes, resulting from selling Tesla stock to finance his purchase of Twitter.
Via
Benzinga
Earn $1000 Every Month From These 3 Stocks
May 11, 2024
All 3 companies pay growing dividends.
Via
The Motley Fool
Top Stock Reports For Amazon.com, Visa & Pfizer
May 10, 2024
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc., Visa Inc.. and Pfizer Inc.
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.